AK Medical Sustainability Profile
AK Medical, officially known as AK Medical Holdings Limited, is a leading player in the orthopaedic medical device industry, headquartered in China. Established in 2002, the company has made significant strides in the development and manufacturing of innovative orthopaedic implants and instruments, primarily serving the Asia-Pacific region and expanding its reach globally. Specialising in joint replacement and trauma products, AK Medical is recognised for its commitment to quality and advanced technology, which sets its offerings apart in a competitive market. The company has achieved notable milestones, including various certifications and partnerships that enhance its market position. With a focus on research and development, AK Medical continues to deliver unique solutions that improve patient outcomes and solidify its reputation as a trusted name in orthopaedics.
DitchCarbon Score
How does AK Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AK Medical's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AK Medical's reported carbon emissions
In 2023, AK Medical Holdings Limited reported no specific carbon emissions data, but it has disclosed its Scope 2 emissions intensity as approximately 5.0 kg CO2e per unit of revenue (CNY). In 2022, the Scope 2 emissions intensity was slightly lower at about 4.0 kg CO2e per unit of revenue. The company has not provided data for Scope 1 or Scope 3 emissions in recent years. Historically, in 2018, AK Medical reported total emissions of 3,693,100 kg CO2e for Scope 3, 1,514,900 kg CO2e for Scope 2, and 99,300 kg CO2e for Scope 1. In 2017, the emissions were 1,425,600 kg CO2e for Scope 3, 1,185,000 kg CO2e for Scope 2, and 242,600 kg CO2e for Scope 1. These figures indicate a significant reliance on indirect emissions, particularly in Scope 3. Despite the absence of specific reduction targets or climate pledges, AK Medical is part of an industry increasingly focused on sustainability. The company has not cascaded any emissions data from a parent organisation, indicating that its reporting is independent. As it moves forward, AK Medical may consider establishing formal reduction targets to align with global climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | |
|---|---|---|
| Scope 1 | 242,600 | 00,000 |
| Scope 2 | 1,185,000 | 0,000,000 |
| Scope 3 | 1,427,600 | 0,000,000 |
How Carbon Intensive is AK Medical's Industry?
How Carbon Intensive is AK Medical's Location?
AK Medical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AK Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
